Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. No study content, eligibility criteria, or results appear to be affected.SummaryDifference0.1%

- Check12 days agoChange DetectedShow glossary was added, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- Revision: v3.3.4 added; Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a 'Locations' section with a Texas site; the 'Texas Locations' label was removed. The footer policy link 'HHS Vulnerability Disclosure' was removed and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check69 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor template/version update and does not modify study details or other user-facing content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, with no other observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.